Genscript CloneArk Plasmid Prep and Gene to Antibody Service.

This is a Notice of Intent to award, not a request for Quotation.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Genscript USA Incorporated, 860 Centennial Ave, Piscataway, NJ 08854 

The Laboratory of Immunogenetics (LIG) has been using GenScript for the past few years for production of human monoclonal antibodies and plasmids for a large number of antibody heavy and light chains and it has proven to support 
our protocols in the projects for cellular and molecular mechanisms that underlie the signaling functions in immune cells.  This service is for Genscript CloneArk Plasmid Prep and Gene to Antibody Service. It is a follow-on service from a previous award to Genscript, award # 75N93021P01394. For continuity of the on-going research, we cannot change variables for service sources that could compromise the integrity of our data and the research results.  

No substitutions are acceptable for this project in order to protect the integrity of the ongoing project and research.

The Place of performance NIH, 5625 Fishers Lane, Rockville, MD  20852 
   
The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements.

THIS IS NOT A REQUEST FOR QUOTES.  

All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2136137 to Diana Rohlman at diana.rohlman@nih.gov by 4:00 PM Eastern Time, August 25, 2022.  All compatibility responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.